Meeting 2025 - HBPSurG

HBPSurG - EFISDS Joint Meeting

Dear Colleagues,

It is our great pleasure to welcome you to the HBPSurG 2025 Meeting in the vibrant city of Lyon, France. This year’s gathering brings together leading experts, surgeons, oncologists, and young specialists in hepatobiliary and pancreatic (HBP) diseases for an exceptional interdisciplinary scientific program dedicated to Learning, Education, and Excellence.

We are thrilled to host you in Lyon, a city renowned for its rich history and contributions to medical innovation. The HBPSurG 2025 Meeting promises to be a dynamic platform for sharing cutting-edge research, state-of-the-art techniques, and transformative ideas in HBP surgery and oncology. We are particularly excited to feature an excellent selection of outstanding speakers, whose expertise and insights will inspire and elevate our discussions. Through keynote lectures, and interactive sessions, we aim to foster collaboration, advance knowledge, and empower the next generation of HBP specialists.

We look forward to engaging sessions that will spark innovation and strengthen connections within our global community of healthcare professionals. Together, let us continue to push the boundaries of excellence in patient care and surgical practice.

Thank you for joining us, and we wish you an enriching and memorable experience at HBPSurG 2025!

Warm regards,

Prof M Adham
Chair of the HBPSurG 2025 Organizing Committee.
On behalf of the HBPSurG 2025 Team

Main Topics

Pre-habilitation & Enhanced Recovery

HBP Malignancies

Recent Advances

Technical Innovations

Sessions

HBPSurG Invited Lectures

Meet the Experts

State-of-the-Art

Free papers

Prof Thilo Hackert — Prof T Hackert
Hamburg

Prof Aleksandar Karamarkovic — Prof A Karamarkovic
Belgrade

Romain L'Huillier — Dr R L’Huillier
Lyon

Prof Luigi Marano — Prof L Marano
Gdańsk

Prof Julia Mayerle — Prof J Mayerle
München

Fabrizio Panaro — Prof F Panaro
Montpellier

Prof Olivier Soubrane — Prof O Soubrane
Paris

Prof Yogesh Vashist — Prof Y Vashist
Goslar

Thursday 30, October

08h30 Onsite Registration

Onsite Registration open all day

08h50 Welcome

Prof M Adham

09h00-10h30 - Meet the Experts

Chairs – A Karamarkovic, JY Mabrut, L Marano

09h00-09h15 – Congenital bile duct dilatation. R L’Huillier, Dept of Radiology, Edouard Herriot Hospital, Lyon, France

09h15-09h30 – Diagnostic & interventional radiology in Klatskin tumor. Dr A Rode (Lyon)

09h30-09h45 – Diagnostic & interventional endoscopy in Klatskin tumor. Prof T Ponchon (Lyon)

09h45-10h00 – Evidence based surgery for Klatskin tumor. Dr X Muller (Lyon)

10h00-10h15 – Robotic surgery for Klatskin tumor. Prof F Panaro (Montpellier)

10h15-10h30 – Questions & Discussion

10h30-11h00 Coffee break

Coffee break

11h00-13h00 - Free papers

Chairs – L Gerard, R L’Huillier, J Navez, A Rode.

11h00-11h10 – Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a multicenter propensity score – matched analysis from Eastern and Western referral centers. Gianluca Cassese, et al. Alessandria, Italy

11h10- 11h20 – Impact of ERAS Compliance on Postoperative Outcomes and Hospital Stay in Liver Surgery. Valerie Nottberg, et al. Department of General, Visceral, and Thoracic Surgery; University Medical Center Hamburg-Eppendorf, Germany.

11h20-11h30 – The resection of the caudate lobe for the treatment of hilar cholangiocarcinoma: our experience. Teresa Perra & Alberto Porcu, Azienda Ospedaliero Universitaria di Sassari, Italy.

11h30-11h40 – Machine Learning for Individualized Survival Prediction in Colorectal Liver Metastases. Ottavia Cicerone, et al. University of Pavia, Italy.

11h40-11h50 – Transition from open to full robotic living donor left liver graft procurement for pediatric recipients-Experience from a western center. Lucas Pflieger et al. Department of General Surgery and Liver Transplantation, Croix-Rousse University Hospital, Hospices Civils de Lyon, France.

11h50 – 12h00 – Comparative effectiveness of immune-targeted and interventional therapies in HCV/HBV-infected vs non-infected patients. Saud Ahmad Saad. West China Hospital, Sichuan University, China.

12h00-12h10 – The impact of tumor burden score on postoperative morbidity and survival in colorectal cancer patients with liver metastases. Anton Burlaka, et al. National Cancer Institute, Kyiv, Ukraine. O. Bogomolets National Medical University, Kyiv, Ukraine.

12h10 – 12h20 – Liver surgery legitimacy in patients with multiple liver metastasis: retrospective analysis. Anton Burlaka, et al. Hepatopancreatobiliary Department of National Cancer Institute, Kyiv, Ukraine. Bogomolets National Medical University National Medical University, Kyiv, Ukraine.

12h20 – 12h30 – Efficacy and Safety of Low-Dose Tacrolimus Monotherapy in Liver Transplantation: Experience from a Level-IV Hospital in Latin America (Cali, Colombia). Ilich Andrei Zúñiga, Universidad del Valle, Cali, Colombia.

12h30-13h00 – Questions & Discussion

13h00-14h00 Lunch break

Lunch Onsite

14h00-14h40 - HBPSurG Invited Lecture

Advances in Liver Surgery for Colorectal Cancer Metastases

Prof David Fuks (Lausanne)

Chair – L Gerard, JY Mabrut

14h45-16h15 - State-of-the-Art

Chairs – J Dumortier, D Fuks, F Panaro

14h45-15h00 – Liver nodules a diagnostic dilemma : Expert vs AI. Dr R L’Huillier (Lyon)

15h00-15h15 – Evidence based update on arterial chemoperfusion for liver. Prof Y Vashist (Goslar)

15h15-15h30 – Evidence based surgery for HCC. Prof JY Mabrut (Lyon)

15h30-15h45 – Management of liver transection surface. Prof A Karamarkovic (Belgrade)

Short Oral Posters

15h45 – 15h50 – Impact of laparoscopic resection for access to the waiting list of a single regional transplant center in southern Italy: entry and dropout flows’ analysis. Roberta Vella et al, Salvatore Gruttadauria Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT-UPMC.

Video

15h50 – 16h00 – Robotic Deceased Donor Liver Transplantation: A Video of Technical Aspects. Mariya Ekimova, Dieter Broreing Organ transplant Center of Excellence, King Faisal Specialist Hospital and Research centre.

16h00-16h15 Questions & Discussion

19h30 - Congress Dinner

Upon Registration

Friday 31, October

08h00 Onsite Registration

Onsite Registration open all day

08h30-10h00 - Meet the Experts

Chairs – J Mayerle, R Salvia, A Durand

08h30-08h45 – Implementation & limitations of pre-habilitation program. Dr J Perinel (Lyon)

08h45-09h00 – Nutrition & pancreatic ductal adenocarcinoma. Dr J Navez (Bruxelles)

09h00-09h15 – Nutrition in cancer patients care. Prof L Marano (Gdańsk)

09h15-09h30 – Pancreatic cancer trials. Dr A Durand (Lyon)

09h30-09h45 Questions & Discussion

10h00-10h45 - HBPSurG Invited Lecture

Pancreatic Ductal Adenocarcinoma : Early Detection ?

Prof Julia Mayerle (München)

Chair – R Gincul, R Salvia

10h40-11h15 Coffee break

Coffee Break

11h15-13h00 - State-of-the-Art

Chairs – J Perinel, J Navez, T Ponchon

11h15-11h30 – Genetic predispositions to pancreatic adenocarcinoma: when to consider it, how to monitor it ? Dr L Calves (Lyon)

11h30-11h45 – Evidence based surgery for PDA. Prof R Salvia (Verona)

11h45-12h00 – Innovations in pancreatic surgery. Prof F Panaro (Alessandria)

12h00-12h15 – Surgery for liver metastases from pancreatic ductal adenocarcinoma. Prof O Soubrane (Paris)

12h15-12h30 – Arterial divestment or resection for locally advanced PDA ? Prof T Hackert (Hamburg)

12h30-13h00 Questions & Discussion

13h00-14h00 Lunch break

Lunch Onsite

14h00-16h00 - Free papers

Chairs – L Calavas, X Muller, Y Vashist, R Vella

14h00-14h10 – The Role of “Conservative” Resection Strategy after neoadjuvant treatment for borderline/locally advanced PDAC with arterial involvement: a single-centre retrospective observational study. Roberta Vella et al. Italy.

14h10-14h20 – Optimizing Surgical Management in High-Risk Pancreatic Resections: Comparative Outcomes of Duct-to-Mucosa and Blumgart Pancreaticojejunostomy Versus Total Pancreatectomy for Postoperative Fistula Prevention. Spiros Delis, et al. Konstantopouleio General Hospital, Surgical Department, Athens, Greece.

14h20-14h30 – Management and outcome of late post-pancreatectomy haemorrhage after pancreatoduodenectomy: experience from a high-volume UK tertiary centre.
Maria Aleksandra Dobrzycka et al. Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham,

14h30-14h40 – Immediate results of laparoscopic spleen-preserving distal pancreatectomy: Kimura vs Warshaw operation. Ilya Vervekin et al. Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.

14h40-14h50 – Critical View of Safety in Laparoscopic Cholecystectomy: A Prospective, Observational Study. Haris Bashir et al. government medical college, srinagar, kashmir, India

Short Oral Posters

Tumor response scoring systems for pancreatic ductal adenocarcinoma: A Systematic Review. Roberta Vella et al. Italy.

The role of neoadjuvant chemotherapy (nCT) in the treatment of patients with resectable pancreatic cancer. Ilya Vervekin et al. Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.

Distal Splenopancreatectomy After Percutaneous Portal Recanalization in the setting of BD-IPMN and Pancreatic Adenocarcinoma Complicated by Portal Cavernoma: A Case Report. Federico Alberto Niccolò Marin et al. Ospedale Papa Giovanni XXIII & Università degli studi di Milano UNIMI, Italy.

Early Laparoscopic Cholecystectomy Post Endoscopic Retrograde cholangiopancreatography in Patients of Cholelithiasis with Choledocholithiasis: An Observational Study. Haris Bashir et al, government medical college, srinagar, kashmir, India.

Video

Lapro-cystoscopic clearance in OCH & Roux-en Y hepaticojejunostomy. Haris Bashir et al, government medical college, srinagar, kashmir, India.

15h30-16h00 Questions & Discussion

16h00 - Rising Star Awards Ceremony

Awards & Certificates for Rising Stars

16h30 Farewell coffee

Farewell coffee

Free Papers Abstract Book

Full abstracts will be displayed on October 30, 2025.

ORAL

Laparoscopic versus open liver resection for huge hepatocellular carcinoma (≥ than 10 cm): a multicenter propensity score – matched analysis from Eastern and Western referral centers. Gianluca Cassese, et al. Alessandria, Italy
The impact of tumor burden score on postoperative morbidity and survival in colorectal cancer patients with liver metastases. Anton Burlaka, et al. National Cancer Institute, Kyiv, Ukraine. O. Bogomolets National Medical University, Kyiv, Ukraine.
Liver surgery legitimacy in patients with multiple liver metastasis: retrospective analysis. Anton Burlaka, et al. Hepatopancreatobiliary Department of National Cancer Institute, Kyiv, Ukraine. Bogomolets National Medical University National Medical University, Kyiv, Ukraine.
Comparative effectiveness of immune-targeted and interventional therapies in HCV/HBV-infected vs non-infected patients. Saud Ahmad Saad. West China Hospital, Sichuan University, China.
Impact of ERAS Compliance on Postoperative Outcomes and Hospital Stay in Liver Surgery. Valerie Nottberg, et al. Department of General, Visceral, and Thoracic Surgery; University Medical Center Hamburg-Eppendorf, Germany.
The resection of the caudate lobe for the treatment of hilar cholangiocarcinoma: our experience. Teresa Perra & Alberto Porcu, Azienda Ospedaliero Universitaria di Sassari, Italy.
Machine Learning for Individualized Survival Prediction in Colorectal Liver Metastases.
Ottavia Cicerone, et al. University of Pavia, Italy.
Transition from open to full robotic living donor left liver graft procurement for pediatric recipients-Experience from a western center. Lucas Pflieger et al. Department of General Surgery and Liver Transplantation, Croix-Rousse University Hospital, Hospices Civils de Lyon, France.
Efficacy and Safety of Low-Dose Tacrolimus Monotherapy in Liver Transplantation: Experience from a Level-IV Hospital in Latin America (Cali, Colombia). Ilich Andrei Zúñiga et al. Universidad del Valle, Cali, Colombia.
Optimizing Surgical Management in High-Risk Pancreatic Resections: Comparative Outcomes of Duct-to-Mucosa and Blumgart Pancreaticojejunostomy Versus Total Pancreatectomy for Postoperative Fistula Prevention. Spiros Delis, et al. Konstantopouleio General Hospital, Surgical Department, Athens, Greece.
Management and outcome of late post-pancreatectomy haemorrhage after pancreatoduodenectomy: experience from a high-volume UK tertiary centre. Maria Aleksandra Dobrzycka, et al. Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, UK.
Immediate results of laparoscopic spleen-preserving distal pancreatectomy: Kimura vs Warshaw operation.
Ilia Vervekin, et al. Pavlov First Saint Petersburg State Medical University. L’va Tolstogo str. 6-8, Saint Petersburg, Russia.
The Role of “Conservative” Resection Strategy after neoadjuvant treatment for borderline/locally advanced PDAC with arterial involvement: a single-centre retrospective observational study. Roberta Vella et al. Italy.
Critical View of Safety in Laparoscopic Cholecystectomy: A Prospective, Observational Study. Haris Bashir et al. government medical college, srinagar, kashmir, India

VIDEO

Robotic Deceased Donor Liver Transplantation: A Video of Technical Aspects. Mariya Ekimova, Dieter Broreing Organ transplant Center of Excellence, King Faisal Specialist Hospital and Research centre.
Lapro-cystoscopic clearance in OCH & Roux-en Y hepaticojejunostomy. Haris Bashir et al, government medical college, srinagar, kashmir, India.

Short Oral Poster

Impact of laparoscopic resection for access to the waiting list of a single regional transplant center in southern Italy: entry and dropout flows’ analysis. Roberta Vella et al, Salvatore Gruttadauria Department for the Treatment and Study of Abdominal Diseases and Abdominal Transplantation, IRCCS-ISMETT-UPMC.
Tumor response scoring systems for pancreatic ductal adenocarcinoma: A Systematic Review. Roberta Vella et al. Italy.
The role of neoadjuvant chemotherapy (nCT) in the treatment of patients with resectable pancreatic cancer.
Ilia Vervekin. et al. Pavlov First Saint Petersburg State Medical University. L’va Tolstogo str. 6-8, Saint Petersburg, Russia.
Distal Splenopancreatectomy After Percutaneous Portal Recanalization in the setting of BD-IPMN and Pancreatic Adenocarcinoma Complicated by Portal Cavernoma: A Case Report. Federico Alberto Niccolò Marin et al. Ospedale Papa Giovanni XXIII& Università degli studi di Milano UNIMI, Italy.
Early Laparoscopic Cholecystectomy Post Endoscopic Retrograde cholangiopancreatography in Patients of Cholelithiasis with Choledocholithiasis: An Observational Study. Haris Bashir et al, government medical college, srinagar, kashmir, India.

Deadline September 15th

Submit Your Abstract Here - CLOSED

Resident & Fellow Speakers

May apply for “Rising Star Award” on abstract submission.
Benefit from free registration (see registration instructions).

HBPSurG 2025

Select Registration Fees Option

Cardholder name

Registration informations

Family Name

First Name

Department & Institution

City

I confirm that I have read and accepted the registration instructions, the privacy policy and confirm that I consent to the processing of my data

Registration Instructions

1/ Click on the “Register here” button, select your registration option, fill & submit the form :

Onsite Attendance
- Standard Registration = 250€
- Standard Registration + Congress Dinner = 330€
- Resident or Fellow < 35Y = 150€
- Resident or Fellow < 35Y + Congress Dinner = 230€
  - Resident or Fellow status confirmation will be requested for validation.
  - Resident or Fellow speakers benefit from free registration (read item 2).
- EFISDS, IASGO & EAHPBA members = 150€
- EFISDS, IASGO & EAHPBA members + Congress Dinner = 230€
  - Society membership status confirmation will be requested for validation.
Online Attendance
- Online attendance = 150€
- After confirmation of registration, a link will be sent on due time to access the virtual meeting platform.

2/ Registration of speakers with an accepted abstract (free papers sessions) :

Registration of speakers is mandatory (Onsite Attendance), otherwise their abstract will be rejected.
Resident or Fellow < 35Y speakers presenting their work in an oral communication :
- May apply for “Rising Stars Awards” on abstract submission.
- Benefit from free registration (Do not submit the “Register here“ form).
- Free registration will be validated upon acceptance of the abstract.

3/ Cancelation Policy :